Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,138 | 983 | 1,228 | 588 | 700 |
| Receivables | 89 | 122 | 84 | 135 | 127 |
| Other current assets | 279 | 41 | 41 | 41 | 41 |
| TOTAL | $2,601 | $1,146 | $1,953 | $1,364 | $1,634 |
| Non-Current Assets | |||||
| PPE Net | 864 | 882 | 911 | 776 | 807 |
| Other Non-Current Assets | 618 | 618 | 0 | 0 | 0 |
| TOTAL | $1,482 | $1,500 | $911 | $776 | $807 |
| Total Assets | $4,083 | $2,646 | $2,864 | $2,140 | $2,441 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 690 | 366 | 329 | 187 | 339 |
| Other current liabilities | 235 | N/A | N/A | N/A | N/A |
| TOTAL | $989 | $862 | $1,007 | $553 | $398 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 55 | 43 | 36 | 56 | 78 |
| TOTAL | $336 | $327 | $325 | $271 | $282 |
| Total Liabilities | $1,325 | $1,189 | $1,332 | $824 | $680 |
| Shareholders' Equity | |||||
| Retained earnings | -25,484 | -24,089 | -22,624 | -20,778 | -19,100 |
| Other shareholders' equity | 2,150 | 1,723 | 1,403 | 1,681 | 1,395 |
| TOTAL | $2,758 | $1,457 | $1,532 | $1,316 | $1,761 |
| Total Liabilities And Equity | $4,083 | $2,646 | $2,864 | $2,140 | $2,441 |